Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Zosano Pharma Corp (ZSAN)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -122.3% | -162.8% | -238.1% | -367.5% | -945.3% | -149.4% | -122.3% | -193.5% |
| ROIC (including intangibles) | -117.8% | -132.0% | -241.0% | -220.5% | -895.1% | -1013.1% | -74.3% | -165.8% |
| ROE | -95.6% | -68.9% | -396.0% | -186.3% | -401.5% | -638.4% | -99.5% | 94.1% |
| ROA | -65.2% | -45.5% | -98.7% | -97.4% | -157.2% | -137.0% | -58.2% | -94.5% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 0.0 | 0.0 | | | | | 0.0 | 14.2 |
| Days payables outstanding | 972.1 | 4,021.4 | | | | | | 5,281.6 |
| Cash conversion cycle | -972.1 | -4,021.4 | | | | | | -5,267.4 |
|